101 related articles for article (PubMed ID: 9609245)
1. Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli--a comparative study of treated and untreated non-surviving baboons challenged with LD100 E. coli.
Randolph MM; White GL; Kosanke SD; Bild G; Carr C; Galluppi G; Hinshaw LB; Taylor FB
Thromb Haemost; 1998 May; 79(5):1048-53. PubMed ID: 9609245
[TBL] [Abstract][Full Text] [Related]
2. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock.
Carr C; Bild GS; Chang AC; Peer GT; Palmier MO; Frazier RB; Gustafson ME; Wun TC; Creasey AA; Hinshaw LB
Circ Shock; 1994 Nov; 44(3):126-37. PubMed ID: 7600636
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
Creasey AA; Chang AC; Feigen L; Wün TC; Taylor FB; Hinshaw LB
J Clin Invest; 1993 Jun; 91(6):2850-60. PubMed ID: 8514893
[TBL] [Abstract][Full Text] [Related]
4. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha).
Hinshaw LB; Tekamp-Olson P; Chang AC; Lee PA; Taylor FB; Murray CK; Peer GT; Emerson TE; Passey RB; Kuo GC
Circ Shock; 1990 Mar; 30(3):279-92. PubMed ID: 2178801
[TBL] [Abstract][Full Text] [Related]
5. Retrospective description and experimental reconstitution of three different responses of the baboon to lethal E. coli.
Taylor FB; Kosanke S; Randolph M; Emerson T; Hinshaw LB; White GL; Chang AC; Peer G; Blick K
Circ Shock; 1994 Feb; 42(2):92-103. PubMed ID: 8013066
[TBL] [Abstract][Full Text] [Related]
6. Prevention or amelioration of morphologic lesions in LD100 E coli-shocked baboons with steroid/antibiotic therapy.
Archer LT; Kosanke SD; Beller BK; Passey RB; Hinshaw LB
Adv Shock Res; 1983; 10():195-215. PubMed ID: 6349298
[TBL] [Abstract][Full Text] [Related]
7. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli.
Taylor FB; Chang AC; Peer G; Li A; Ezban M; Hedner U
Blood; 1998 Mar; 91(5):1609-15. PubMed ID: 9473226
[TBL] [Abstract][Full Text] [Related]
8. Retrospective study comparing the pathophysiology of antibiotic-treated and untreated Escherichia coli- and Staphylococcus aureus-infused baboons.
He S; Hinshaw L; Emerson T; Kosanke S; White G; Randolph MM; Chang AK; Duerr M; Peer G; Passey R
Circ Shock; 1993 Oct; 41(2):88-102. PubMed ID: 8242885
[TBL] [Abstract][Full Text] [Related]
9. Studies on the inflammatory-coagulant axis in the baboon response to E. coli: regulatory roles of proteins C, S, C4bBP and of inhibitors of tissue factor.
Taylor FB
Prog Clin Biol Res; 1994; 388():175-94. PubMed ID: 7831358
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis.
Sabharwal AK; Bajaj SP; Ameri A; Tricomi SM; Hyers TM; Dahms TE; Taylor FB; Bajaj MS
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):758-67. PubMed ID: 7881667
[TBL] [Abstract][Full Text] [Related]
11. Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons.
Taylor FB; Emerson TE; Jordan R; Chang AK; Blick KE
Circ Shock; 1988 Nov; 26(3):227-35. PubMed ID: 3061681
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of tissue factor pathway inhibitor (TFPI) as topically applied antithrombotic agent.
Aagaard S; Hjortdal VE; Barker JH
APMIS Suppl; 2003; (109):102-7. PubMed ID: 12874959
[TBL] [Abstract][Full Text] [Related]
13. Fragmented tissue factor pathway inhibitor (TFPI) and TFPI C-terminal peptides eliminate serum-resistant Escherichia coli from blood cultures.
Schirm S; Liu X; Jennings LL; Jedrzejewski P; Dai Y; Hardy S
J Infect Dis; 2009 Jun; 199(12):1807-15. PubMed ID: 19456231
[TBL] [Abstract][Full Text] [Related]
14. Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shock.
Matyal R; Vin Y; Delude RL; Lee C; Creasey AA; Fink MP
Intensive Care Med; 2001 Aug; 27(8):1274-80. PubMed ID: 11511939
[TBL] [Abstract][Full Text] [Related]
15. Escherichia coli shock in the baboon and the response to adrenocorticosteroid treatment.
Hinshaw LB; Coalson JJ; Benjamin BA; Archer LT; Beller BK; Kling OR; Hasser EM; Phillips RW
Surg Gynecol Obstet; 1978 Oct; 147(4):545-57. PubMed ID: 100890
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of treatment with the iron (III) complex of diethylenetriamine pentaacetic acid in mice and primates inoculated with live lethal dose 100 Escherichia coli.
Molina L; Studenberg S; Wolberg G; Kazmierski W; Wilson J; Tadepalli A; Chang AC; Kosanke S; Hinshaw L
J Clin Invest; 1996 Jul; 98(1):192-8. PubMed ID: 8690793
[TBL] [Abstract][Full Text] [Related]
17. The role of tissue factor pathway inhibitor in tumor growth and metastasis.
Amirkhosravi A; Meyer T; Amaya M; Davila M; Mousa SA; Robson T; Francis JL
Semin Thromb Hemost; 2007 Oct; 33(7):643-52. PubMed ID: 18000790
[TBL] [Abstract][Full Text] [Related]
18. Relationship of serum gentamicin levels and methylprednisolone sodium succinate treatment in baboons challenged with Escherichia coli LD100.
Flournoy DJ; Beller BK; Archer LT; Hinshaw LB
Clin Ther; 1983; 5(4):417-21. PubMed ID: 6347383
[TBL] [Abstract][Full Text] [Related]
19. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
20. Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2.
Rao CN; Reddy P; Reeder DJ; Liu Y; Stack SM; Kisiel W; Woodley DT
Biochem Biophys Res Commun; 2000 Oct; 276(3):1286-94. PubMed ID: 11027624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
